Myovant Sciences Ltd (MYOV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Sales | 77,902 | 41,063 | 24,605 | 1,379 | 0 |
| Cost of Goods | 2,622 | 1,032 | N/A | N/A | N/A |
| Gross Profit | 75,280 | 40,031 | 24,304 | 1,379 | N/A |
| Operating Expenses | 94,248 | 97,385 | 101,554 | 79,696 | 71,837 |
| Operating Income | -18,346 | -57,322 | -76,949 | -78,317 | -71,837 |
| Interest Expense | 3,494 | 3,505 | 3,493 | 2,609 | 2,115 |
| Other Income | 100 | 78 | 31 | 5,923 | 6,756 |
| Pre-tax Income | -21,740 | -60,749 | -80,411 | -75,003 | -67,196 |
| Income Tax | -149 | 911 | 952 | -1,154 | -134 |
| Net Income Continuous | -21,591 | -61,660 | -81,363 | -73,849 | -67,062 |
| Net Income | $-21,591 | $-61,660 | $-81,363 | $-73,849 | $-67,062 |
| EPS Basic Total Ops | -0.23 | -0.67 | -0.89 | -0.82 | -0.75 |
| EPS Basic Continuous Ops | -0.23 | -0.67 | -0.90 | -0.82 | -0.75 |
| EPS Diluted Total Ops | -0.23 | -0.67 | -0.89 | -0.82 | -0.75 |
| EPS Diluted Continuous Ops | -0.23 | -0.67 | -0.90 | -0.82 | -0.75 |
| EPS Diluted Before Non-Recurring Items | -0.23 | -0.67 | -0.89 | N/A | N/A |
| EBITDA(a) | $-17,534 | $-56,598 | $-75,622 | $-77,676 | $-71,242 |